HCPCS Code Descriptor:
Injection, elosulfase alfa, 1 mg
Enzyme Replacement Therapy
Route of Administration:
VIMIZIM is an Enzyme Replacement Therapy drug manufactured by Biomarin Pharma and administered via the Intravenous route of administration. The J Code: J1322 is aligned to the drug VIMIZIM.